-
MPC-Driven Lactate, Histone Lactylation, and Tumor Immunity
2026-04-30
This study uncovers how mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer elevates lactate, driving histone lactylation in dendritic cells and dampening anti-tumor immunity. The findings suggest precise metabolic modulation, such as LDH inhibition, could enhance immunotherapy efficacy by altering the tumor microenvironment.
-
Neuromedin S (rat): Technical Use and Workflow Best Practice
2026-04-29
Neuromedin S (rat) provides a validated, endogenous peptide agonist for studying neuromedin U receptor signaling in rat GPCR/G protein research. It is intended for controlled laboratory use only and is not suitable for diagnostic or therapeutic applications. Adhering to defined solubility, storage, and handling protocols is critical for reproducibility.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Decoding Early Apoptosis
2026-04-29
Discover how the Annexin V-Cy5/DAPI Apoptosis Kit advances apoptosis detection by enabling rapid, high-fidelity analysis of programmed cell death. Explore novel insights and practical guidance for researchers seeking superior assay precision.
-
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Precisi
2026-04-28
Sulfo-Cy3 NHS ester stands out as a hydrophilic fluorescent dye, streamlining protein and peptide labeling in aqueous environments. Its high water solubility and minimized quenching empower robust, reproducible assays for sensitive biomolecular detection—critical for vascular biology and translational research.
-
Technical Use of Anti-HMGB1 Rabbit Monoclonal Antibody (MA30
2026-04-28
The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) enables targeted detection of HMGB1 protein in human, mouse, and rat samples, supporting Western blot, immunohistochemistry, and flow cytometry workflows. This reagent is intended for research use only and is not suitable for diagnostic or therapeutic applications.
-
CircNUP54 Drives HCC via HuR Export and BIRC3 mRNA Stabiliza
2026-04-27
This study uncovers the oncogenic role of circNUP54 in hepatocellular carcinoma (HCC), showing how it promotes tumor progression by facilitating the cytoplasmic export of HuR and stabilizing BIRC3 mRNA. These findings highlight a distinct circRNA-mediated mechanism in HCC and identify potential molecular targets for therapeutic intervention.
-
RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti
2026-04-27
Harper et al. (2025) reveal that cell death following RNA Pol II inhibition is not simply due to loss of transcription, but is activated by a dedicated apoptotic signaling pathway sensing loss of the hypophosphorylated RNA Pol IIA subunit. This paradigm-shifting discovery uncovers a mitochondria-linked cell death mechanism, informing both fundamental biology and strategies for optimizing apoptosis induction in cancer research.
-
Machine Learning-Guided Prediction of LNPs for mRNA Vaccines
2026-04-26
This study introduces a machine learning framework to predict the efficacy of lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, moving beyond traditional experimental screening. The model identifies key ionizable lipid substructures and demonstrates predictive power validated by animal experiments, offering a scalable strategy for rational LNP design.
-
Copper-Catalyzed Radical Cyclization for Thioazafluoranthene
2026-04-25
This study presents a copper-catalyzed tandem radical cyclization method for synthesizing sulfur/nitrogen-doped fluoranthenes, specifically 2H-benzo[e][1,2]thiazine 1,1-dioxides, under mild conditions and in good yields. The approach enables efficient access to novel heteroatom-doped polycyclic scaffolds with distinct fluorescence properties, potentially benefiting optoelectronic and sensing applications.
-
Spatially Patterned Kidney Assembloids Advance Disease Model
2026-04-24
Huang et al. present spatially patterned human kidney progenitor assembloids (hKPAs) that recapitulate complex self-assembly and maturation, overcoming major limitations of previous kidney organoid models. This innovation enables high-fidelity modeling of kidney disease and offers robust potential for regenerative medicine research.
-
Wnt Signaling Regulates DNA Damage Response via EGFR in Dros
2026-04-24
Ewen-Campen and Perrimon (2024) uncover how canonical Wnt signaling in Drosophila wing discs mitigates apoptosis following DNA damage by activating EGFR signaling. Their mechanistic insights into pathway crosstalk clarify how developmental signaling confers tissue robustness to genomic stress, with implications for understanding chemoresistance in cancer biology.
-
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-04-23
This study demonstrates that naturally occurring angiotensin peptides, particularly specific C- and N-terminal fragments, markedly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings reveal a novel cross-talk between the renin-angiotensin system and viral entry pathways, with important implications for COVID-19 pathogenesis and future therapeutic targeting.
-
Targeted mRNA Delivery to Islet β Cells via Conjugated LNPs
2026-04-23
Enriquez et al. present a lipid nanoparticle (LNP) system conjugated with eGLP-1 for selective and functional mRNA delivery to islet β cells, enabling immune modulation in type 1 diabetes. Their approach achieves β cell enrichment, induces PD-L1 expression, and delays disease onset in preclinical models, opening new avenues for precision mRNA therapeutics.
-
Semi-Automated Screening for Fast-Dissociating V5 Tag Antibo
2026-04-22
Miyoshi et al. introduce a semi-automated single-molecule microscopy method to identify fast-dissociating, specific monoclonal antibodies, including those targeting the V5 epitope tag. This approach enables rapid selection of antibodies with transient binding kinetics, advancing multiplexed super-resolution imaging and real-time protein dynamics studies.
-
Difloxacin HCl: Quinolone Antimicrobial Antibiotic for MDR R
2026-04-22
Difloxacin HCl streamlines both antimicrobial susceptibility testing and multidrug resistance reversal workflows, empowering translational studies in microbiology and oncology. Its validated solubility and high purity, backed by APExBIO, enable reproducible results and protocol flexibility in advanced research contexts.